Initiate a PDE5 Inhibitor as First-Line Therapy
Start this patient on a PDE5 inhibitor (sildenafil, tadalafil, vardenafil, or avanafil), selecting the specific agent based on his intercourse frequency and personal preference 1. This is the established first-line treatment for erectile dysfunction in men with his profile, including those with diabetes, hypertension, and hyperlipidemia.
Why PDE5 Inhibitors Are the Clear Choice
The 2025 European Association of Urology guidelines explicitly recommend PDE5 inhibitors as first-line therapy for erectile dysfunction 1. The Princeton III Consensus confirms their cardiovascular safety, with extensive placebo-controlled and post-marketing data showing no new cardiovascular concerns 2. In fact, PDE5 inhibitors may improve endothelial function and vascular health in patients with cardiovascular risk factors 2.
For this 83-year-old active patient with well-controlled diabetes and cardiovascular risk factors, PDE5 inhibitors are both effective and safe 3, 4. Studies specifically in diabetic men with cardiovascular risk factors demonstrate 56-62% improvement rates with sildenafil versus 10-18% with placebo 3, 4.
Selecting the Specific PDE5 Inhibitor
The choice depends on two key factors 1:
- Intercourse frequency: If he has sex infrequently (once or twice weekly), use on-demand shorter-acting agents (sildenafil 50-100mg, vardenafil 10-20mg, or avanafil 100-200mg taken 30-60 minutes before activity)
- If he desires spontaneity or more frequent activity: Consider tadalafil 5mg daily or 10-20mg on-demand (effective for up to 36 hours)
Age-Specific Considerations
Elderly men respond well to PDE5 inhibitors, though efficacy may be slightly lower than in younger men 5, 6. In men over 70 years, sildenafil improved IIEF scores from 8.2 to 21 (near-normalization), with 65.7% efficacy 5, 6. Start with lower doses in elderly patients: sildenafil 25-50mg rather than 100mg 5.
Diabetes-Specific Factors
His diet-controlled diabetes is actually favorable. Men with diabetes show 56-74% response rates to sildenafil, though this is lower than the general population's 75-89% 3, 6, 4. The presence of diabetes does not contraindicate PDE5 inhibitors; it simply means expectations should be realistic 7.
Cardiovascular Safety in This Patient
His cardiovascular profile is low-risk:
- Well-controlled hypertension and hyperlipidemia
- Walks 2 miles daily (demonstrates good functional capacity >3-5 METs)
- No history of recent cardiac events
The Princeton III Consensus classifies such patients as low-risk, meaning they can safely engage in sexual activity and use PDE5 inhibitors without cardiac evaluation 2. Sexual activity requires approximately 3-5 METs, which he clearly exceeds with his daily walking routine.
Expected Adverse Effects
Common side effects are mild and include 1, 5, 3:
- Headache (5-11%)
- Flushing (6-7%)
- Dyspepsia (2-9%)
- Nasal congestion (6%)
These are typically mild to moderate and rarely lead to discontinuation 5. In elderly patients specifically, no age-specific adverse effects have been identified 5, 6.
Critical Contraindications to Verify
Before prescribing, confirm he is NOT taking:
- Nitrates (nitroglycerin, isosorbide) - absolute contraindication
- Alpha-blockers (may require dose adjustment or timing separation)
His antihypertensive regimen should be reviewed. If possible, favor agents less likely to worsen erectile dysfunction, such as ACE inhibitors, ARBs, or nebivolol over traditional beta-blockers or thiazide diuretics 2.
Optimizing Treatment Success
Proper patient education is essential 1:
- Take medication on an empty stomach or after light meal (fatty meals delay absorption)
- Timing: 30-60 minutes before sexual activity for most agents
- Sexual stimulation is required - the medication does not cause automatic erections
- May require 4-8 attempts before determining efficacy
If PDE5 Inhibitors Fail
Should he not respond adequately 1:
- First verify proper use: correct timing, adequate sexual stimulation, sufficient trial period
- Check morning testosterone level - if low (<230-350 ng/dL), add testosterone replacement therapy 1, 2
- Consider switching to a different PDE5 inhibitor (though evidence for this is limited) 1
- Second-line options include intracavernosal injections, intraurethral alprostadil, or vacuum erection devices 1
Practical Prescribing Approach
Start with sildenafil 50mg or tadalafil 10mg on-demand, taken 1 hour before anticipated sexual activity 5, 4. Adjust based on efficacy and tolerability after 4-8 attempts. In elderly patients, starting at lower doses (sildenafil 25mg) is reasonable but often requires uptitration 5.